These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 2963968)
21. The renal and vascular effects of central angiotensin II and atrial natriuretic factor in the anaesthetized rat. Al-Barazanji KA; Balment RJ J Physiol; 1990 Apr; 423():485-93. PubMed ID: 2143782 [TBL] [Abstract][Full Text] [Related]
22. Central administration of 5-HT activates 5-HT1A receptors to cause sympathoexcitation and 5-HT2/5-HT1C receptors to release vasopressin in anaesthetized rats. Anderson IK; Martin GR; Ramage AG Br J Pharmacol; 1992 Dec; 107(4):1020-8. PubMed ID: 1467825 [TBL] [Abstract][Full Text] [Related]
23. Vagal afferent-mediated inhibition of a nociceptive reflex by intravenous serotonin in the rat. I. Characterization. Meller ST; Lewis SJ; Ness TJ; Brody MJ; Gebhart GF Brain Res; 1990 Jul; 524(1):90-100. PubMed ID: 2400935 [TBL] [Abstract][Full Text] [Related]
24. Hemodynamic pharmacology of p-chloroamphetamine, a serotonin agonist, in conscious rats. Alper RH; Lee C; Brody MJ J Pharmacol Exp Ther; 1987 Nov; 243(2):446-54. PubMed ID: 3681694 [TBL] [Abstract][Full Text] [Related]
25. Central effects of angiotensin II in water and saline loaded rats. Hoffman WE; Weet JF; Phillips MI; Schmid PG Neuroendocrinology; 1979; 28(5):289-96. PubMed ID: 440532 [TBL] [Abstract][Full Text] [Related]
26. Serotonergic involvement in the cardiovascular stimulation by thyrotropin-releasing hormone (TRH) in anesthetized rats. Nurminen ML; Paakkari I; Seppälä T Neurosci Lett; 1991 Jun; 127(2):147-9. PubMed ID: 1715540 [TBL] [Abstract][Full Text] [Related]
27. Serotonin involvement in aversive conditioning: reversal of the fear retention deficit by long-term p-chloroamphetamine but not p-chlorophenylalanine. Archer T; Ogren SO; Ross SB Neurosci Lett; 1982 Dec; 34(1):75-82. PubMed ID: 6219302 [TBL] [Abstract][Full Text] [Related]
28. Separation of the associative and non-associative effects of brain serotonin released by p-chloroamphetamine: dissociable serotoninergic involvement in avoidance learning, pain and motor function. Ogren SO; Johansson C Psychopharmacology (Berl); 1985; 86(1-2):12-26. PubMed ID: 3927348 [TBL] [Abstract][Full Text] [Related]
29. Attenuation of morphine-induced analgesia by p-chlorophenylalanine and p-chloroamphetamine: test-dependent effects and evidence for brainstem 5-hydroxytryptamine involvement. Berge OG; Hole K; Ogren SO Brain Res; 1983 Jul; 271(1):51-64. PubMed ID: 6224533 [TBL] [Abstract][Full Text] [Related]
30. Hypothalamic paraventricular, but not supraoptic neurons, mediate the serotonergic stimulation of oxytocin secretion. Van de Kar LD; Rittenhouse PA; Li Q; Levy AD; Brownfield MS Brain Res Bull; 1995; 36(1):45-50. PubMed ID: 7882048 [TBL] [Abstract][Full Text] [Related]
31. Forebrain serotonin and avoidance learning: behavioural and biochemical studies on the acute effect of p-chloroamphetamine on one-way active avoidance learning in the male rat. Ogren SO Pharmacol Biochem Behav; 1982 Jun; 16(6):881-95. PubMed ID: 7111347 [TBL] [Abstract][Full Text] [Related]
32. Central serotonin neurones in avoidance learning: interactions with noradrenaline and dopamine neurones. Ogren SO Pharmacol Biochem Behav; 1985 Jul; 23(1):107-23. PubMed ID: 2994116 [TBL] [Abstract][Full Text] [Related]
33. Effects of central and peripheral neuropeptide Y on sodium and water excretion in the rat. Smyth DD; Wilson JR; Seidlitz E; Thom SL Physiol Behav; 1989 Jul; 46(1):9-11. PubMed ID: 2813560 [TBL] [Abstract][Full Text] [Related]
34. Effects of para-chloroamphetamine upon the serotonergic innervation of the rat hippocampus. Haring JH; Meyerson L; Hoffman TL Brain Res; 1992 Apr; 577(2):253-60. PubMed ID: 1606500 [TBL] [Abstract][Full Text] [Related]
35. p-Chloroamphetamine, a serotonin-releasing drug, elicited in rats a hyperglycemia mediated by the 5-HT1A and 5-HT2B/2C receptors. Yamada J; Sugimoto Y; Yoshikawa T Eur J Pharmacol; 1998 Oct; 359(2-3):185-90. PubMed ID: 9832390 [TBL] [Abstract][Full Text] [Related]
36. Effect of intracerebroventricular administration of dopamine on urinary function in goats. Vandeputte-Van Messom G; Peeters G Arch Int Pharmacodyn Ther; 1979 Sep; 241(1):108-20. PubMed ID: 526066 [TBL] [Abstract][Full Text] [Related]
37. Effects of Helichrysum ceres extracts on renal function and blood pressure in the rat. Musabayane CT; Munjeri O; Mdege ND Ren Fail; 2003 Jan; 25(1):5-14. PubMed ID: 12617328 [TBL] [Abstract][Full Text] [Related]
38. Sodium excretion following central administration of an I1 imidazoline receptor agonist, moxonidine. Penner SB; Smyth DD Br J Pharmacol; 1994 Aug; 112(4):1089-94. PubMed ID: 7952868 [TBL] [Abstract][Full Text] [Related]
39. Sleep suppressant action of fenfluramine in rats. II. Evidence against the involvement of presynaptic serotonergic mechanism. Fornal C; Radulovacki M J Pharmacol Exp Ther; 1983 Jun; 225(3):675-81. PubMed ID: 6223135 [TBL] [Abstract][Full Text] [Related]